Enters Regulatory Testing Phase for Updated myCam Cardiac Event Monitoring Device

Enhanced product to include significant operating enhancements and material design advances over the current offering

CB Scientific, Inc. Welcomes James Ott as Chief Technology Officer

Newly created position to spearhead technological innovation in the next stage of growth

CB Scientific, Inc. Announces Uplist to the OTCQB Venture Market

Shareholders to benefit from greater transparency and improved liquidity on OTCQB

CB Scientific, Inc. Concludes its Annual Audit with MaloneBailey, LLP

Achieving major milestone squarely positions the Company for uplisting to the OTCQB® Venture Market

CB Scientific, Inc. Concludes its Special Meeting of Stockholders

Commanding shareholder approval better positions management to attain enterprise business objectives going forward.

CB Scientific, Inc. to Convene a Special Meeting of Stockholders on Friday, January 14, 2022

Agenda includes transformational matters affecting the Company’s position to manage impending growth

Entered Beta-testing Phase for Updated Proprietary My-Cam Cardiac Event Monitor

Updates to provide device improvements while maintaining the innovative core-functionality of CBSC’s state of the art cardiac event monitor.

Executed Manufacturing Letter of Intent with Shenzhen Pump Medical System Co., Ltd.

Partnership to provide high-volume manufacturing capability and facilitate obtaining requisite government approvals.

Announcing Intent to Convene a Special Meeting of the Stockholders

Agenda to include matters necessary to better position the company for anticipated growth and development.

Application Filed to Uplist to the OTCQB Venture Market

Upgraded listing would provide increased transparency and enhanced trading efficiency.

Looking for quarterly reports? View our financial statements.

Get our news in your inbox!

Join our newsletter and we will send our news directly to you.